Cryo-Cell International, Inc. Quarterly report pursuant to Section 13 or 15(d)

Income (Loss) per Common Share (Tables)

6 Months Ended

May 31, 2014

The following table sets forth the calculation of basic and diluted net income (loss) per common share:


	Three Months Ended					Six Months Ended
	May 31, 2014		May 31, 2013			May 31, 2014		May 31, 2013
Numerator:
Net Income (Loss)	$	215,773	($	243,658	)	$	612,885	$	348

Denominator:
Weighted-average shares outstanding-basic		10,250,471		10,946,743			10,467,914		10,964,370
Dilutive common shares issuable upon exercise of stock options		156,136		—			127,676		118,194

Weighted-average shares-diluted		10,406,607		10,946,743			10,595,590		11,082,564

Net income (loss) per common share:
Basic	$	0.02	($	0.02	)	$	0.06	$	0.00

Diluted	$	0.02	($	0.02	)	$	0.06	$	0.00